Lucy Sharples is an associate in Goodwin’s Technology and Life Sciences groups. She has experience in advising on a range of commercial and regulatory matters for life sciences companies, including licensing and collaboration agreements, manufacturing and services agreements and clinical trial agreements. Lucy also advises on the intellectual property, commercial and regulatory aspects of venture capital investments, M&A transactions and IPOs, and provides regulatory advice on medicinal product and medical device issues.

Lucy has a background in medicine and healthcare, having studied medical sciences at the University of Cambridge.

Areas of Practice
Domaines D’Expertise





Lucy’s recent experience includes:

  • Advised Forbion Capital and Sofinnova Investments on its jointly led a $148 million series C investment round in Gyroscope Therapeutics Limited.
  • Advised Forbion Capital on the first tranche of its £20 million investment in Oxular Limited as part of Oxular’s £27 million Series A1 funding round.
  • Advised Vaccitech plc (Nasdaq: VACC) on its initial public offering of 6,500,000 American Depositary Shares representing 6,500,000 ordinary shares at an initial public offering price of $17 per ADS.
  • Advised COMPASS Pathways plc on its public follow-on offering of 4,000,000 American Depositary Shares representing 4,000,000 ordinary shares at a public offering price of $36 per share, for gross proceeds of approximately $144 million.
  • Advised MiNA Therapeutics Limited on its Research and Collaboration Agreement with Eli Lilly and Company.
Professional Experience
Prior to joining Goodwin, Lucy was an associate at Taylor Wessing LLP.

In The News









Postgraduate Diploma in Intellectual Property Law and Practice, 2020
University of Oxford
M.A., Legal Practice Course with Business, 2017
BPP University Law School
Graduate Diploma in Law, 2016
BPP University Law School
B.A. (Honours), Medical Sciences, 2015
University of Cambridge



Solicitor of the Senior Courts of England and Wales
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique